“Tobacco and vaping industry representatives are not accepted to attend this event. The same rule applies to any entity or individual advancing their interests linked to the tobacco and vaping industry in a commercial or non-commercial manner. There is a fundamental and irreconcilable conflict between the tobacco industry’s interests and public health policy interests. (WHO FCTC Article 5.3 – Guiding Principles)”.
David Zaruk was one of the people who applied anyway, and he wrote about the experience for us last week.
I was another. Here’s my experience, which is replicated more or less exactly among all six people I know who applied:
Mon 2 Nov, 13:00: Invitation from The Parliament Magazine Events, “Masterclass Invitation: Latest scientific evidence on emerging nicotine products, use among young people and health risks”. The event is led by NGO and disgraced Commission tobacco policy contractor the European Network for Smoking Prevention; sponsored by NRT maker Kenvue; and hosted by French Socialist MEP Christophe Clergeau .
Mon 2 Nov, 13:20: Registration acknowledgement. It says requests will be reviewed, and it carries the exclusion rule citing Article 5.3 of the WHO tobacco treaty.
Fri 6 Nov, 11:09: Rejection, subject “Registration cancellation”. The stated reason is that the event “has reached full capacity”.
Wed 11 Nov, 15:01: “Final call” email: “Places are filling fast… Registrations close in just a few days.”
Wed 11 Nov, 15:09: I replied to customer service, copying Stephanie Semeraro (sponsorship director at the Parliament Magazine), asking whether the event was full.
To date: No reply.
In short, we’ve been invited, then told we can’t come because the event is full, which is an obvious lie since a week later we were invited to register again. We presume we’ve been excluded because of who we are: people who advocate in favour of tobacco harm reduction.
The purity test language is broader than I’ve ever seen. On a simple reading, the addition of “non-commercial manner” essentially means anyone whose views happen to coincide with those of the tobacco industry is persona non grata. That includes vast swathes of respected academia, think tankers, volunteer consumer groups and the media (including event hosts the Parliament Magazine itself, which we will come onto in a moment). In other words, this is about what you think, not who you work for.
Now, it’s one thing to have a private event in Parliament and only invite your friends. This isn’t that. This is MEPs, the pharmaceutical industry and a well established media outlet saying they want to inform the world about science, and then saying only those who agree with them on the science are allowed to have a voice.
Nicotine users, private media outlets like mine and people who write about harm reduction for us like David are, in the main, EU taxpayers. While Kenvue will be paying for the coffee and pastries at this event, the building it’s held in is financed by taxpayers. And those same taxpayers and being told they can’t go to an event held there because of their views on a particular subject.
Feels kinda…Soviet.
Parliament’s rules
The problem is, WHO’s Article 5.3 doesn’t apply in the European Parliament, the organisers know this, and they’re trying to get around it.
The question of whether the tobacco industry itself could speak to Members of Parliament was resolved six months ago. A group of MEPs campaigning for more bans wrote to the Parliament’s constitutional affairs committee to try and get European Parliament badges taken away from tobacco companies.
The letter they got back from the Committee’s chair, German MEP Sven Simon, is such a stinging rebuke that we’re publishing it in full here (as far as I’m aware, it’s not been put in the public domain by anyone else).
“Once Parliament accepts the principle that its Rules of Procedure may be used to determine circumstances in which Members may be restricted from meeting, consulting or hearing lawful actors, the issue ceases to be one of tobacco control. It becomes a question about the scope of parliamentary independence itself” Simon writes.
“Parliamentary democracy is founded on the assumption that elected representatives are capable of exercising independent judgement. The role of the Rules of Procedure is to guarantee transparency, integrity and accountability in the exercise of the mandate. It is not to prescribe in advance which lawful viewpoints may be heard or which lawful actors may participate in parliamentary deliberation. Such an approach would represent a significant departure from the traditionally open, pluralistic and representative character of parliamentary democracy”.
But what of the argument that issues related to tobacco and nicotine are fundamentally different because of the WHO’s Treaty on Tobacco Control and its Article 5.3, used by ENSP and Kenvue to keep us out? Simon is pretty clear there, too:
“As regards Article 5.3 of the FCTC, the Committee is not persuaded that the provision requires the introduction of sector-specific restrictions into Parliament’s Rules of Procedure” he writes.
“The obligation to protect public health policies from vested interests must be implemented in a manner consistent with the constitutional principles governing the functioning of the European Parliament…Furthermore, neither the text of the Convention nor its implementation guidelines appear to require the introduction of specific restrictions on contacts between elected representatives and representatives of a lawful economic sector”.
Quite right too. Exclusionary policies seem like a great idea until they are applied to you. The NGO community would be rightly outraged if Shell and BP organised an event on climate change and refused to let the head of EU affairs for Greenpeace in. In a free society, no one has a monopoly on truth or virtue.
The Parliament Magazine as host
But if we think exclusion is acceptable in this instance, that should extend to the event’s host, the Parliament Magazine.
Clearing the Air is funded by paid ads, which are difficult to come by given that it’s largely illegal to advertise vapes in the EU, and a grant from the Consumer Choice Center. The Center, in turn, is funded by grants from various tobacco and nicotine companies. We don’t hide this and neither do they.
The Parliament Magazine does the same. It is, and continues to be, more than happy to publish sponsored content from, and host events financed by, nicotine industry stakeholders. A couple of minutes with a search engine turns up:
Two articles in the last 18 months written by executives from British American Tobacco.
Two articles from 2022 sponsored by Japan Tobacco International
Events from organisations like We are Innovation and Smoke Free Sweden which advocate in favour of tobacco harm reduction and have links to the tobacco industry. (For what it’s worth, I went to both and participated in one).
None of this has been hidden from public view, so one wonders why ENSP and Kenvue think that the Parliament Magazine is somehow exempt from its WHO-mandated omerta. And if the Parliament Magazine can take money from tobacco-tainted organisations and still participate in a debate with “polite society”, why can’t Clearing the Air?
Why can’t David Zaruk, our occasional contributor who wrote the original letter to the Parliament, go? Yes, we pay him to write for us, as well we should. My father was a freelance journalist and we don’t take free copy on principle. And why can’t Alex Gogoana from ACPAN go? They don’t even have a bank account, and so can’t take tainted money. Even the EU Commission has been forced to admit that ACPAN isn’t covered by Article 5.3.
Kenvue as sponsors
Then there’s the sponsor. Kenvue is the consumer health company spun out of Johnson & Johnson, and it makes Nicorette.
That matters, because the event isn’t about smoking. It’s about “recreational nicotine”: vapes, pouches and heated tobacco. That isn’t a neutral scientific term. It’s Kenvue’s own marketing vocabulary. Its TOTAL QUIT campaign calls for an end to “dependence on all forms of recreational nicotine”. It asks governments to regulate vape packaging and flavour descriptors, and to review the nicotine strength of recreational products. When an event in the European Parliament takes its title from a sponsor’s campaign, readers can work out who set the agenda.
Kenvue isn’t a disinterested party to that agenda. Vapes and pouches compete directly with Nicorette for the custom of smokers who want to quit, and on the best available evidence they are winning. The Cochrane review finds that nicotine e-cigarettes help more people stop smoking than nicotine replacement therapy. And as Mitch Zeller, the former head of the FDA’s tobacco control unit, said in an interview recently, NRT’s just don’t really work in the real world.
None of this is hidden. Kenvue says on its own website that in 2025 it joined discussions with the WHO, ENSP and EU policymakers on youth nicotine addiction. Its EMEA self-care vice president has written in The Parliament Magazine calling for tighter regulation, marketing restrictions and access controls on the same products.
I don’t think Kenvue should be kept out of the room. It has a commercial interest and a view, and it is entitled to put both to MEPs. So is everyone else. Look again at the rule that kept us out: no “entity or individual advancing their interests… in a commercial or non-commercial manner”, because there is a “fundamental and irreconcilable conflict” between commercial interests and public health policy. Applied evenly, that sentence excludes the company paying for the coffee.
It isn’t applied evenly, because Article 5.3 covers only the tobacco industry. A pharmaceutical company that profits when governments restrict its competitors is, by that definition, simply a public health partner. Under this rule a conflict of interest doesn’t depend on whether you make money from the outcome. It depends on which side you’re on.
And then there’s the lying
The organisers must know that we are perfectly entitled to attend a public event in the European Parliament, which is presumably why they didn’t say that we were being rejected because of who we are, but because the event was apparently full.
It’s one thing saying you’re having a private event and only those invited can go. It’s completely different to open up registration to the public, send around an email encouraging people to register, then refuse the registrations of people who responded to that email saying the event was full but leaving registration open, and then sending emails to those same people a few days later telling them it’s their last chance to register.
I won’t be going to this, but I totally expect to see pictures of a half empty room when they are published.
So what can we learn from this rather sorry experience?
It’s that there is a certain segment of the European public health elite - some MEPs and EU-funded NGOs - who hold sections of the EU population they disagree with in such utter contempt that they assume they couldn’t possibly hold such awful views unless they were in the pay of big tobacco. There are others - pharmaceutical companies and publishers - who hold them in similar contempt, but use hypocrisy as their weapon of choice.
I’ve said it before and I will say it again. This is how populism develops.
It’s also clear that the event isn’t about science at all. Science is about testing a claim against the people best placed to knock it down; an event that vets its audience to remove them first isn’t examining the evidence, it’s rehearsing a conclusion. And that’s the sorry state of tobacco control today: so weak is their factual position on lower risk products that the only way they can get their message across is by stopping anyone from challenging it and slandering those who try.